Join the club for FREE to access the whole archive and other member benefits.

Artificial Intelligence-based Biomarkers of Ageing

NUS Healthy Longevity webinar with Alex Zhavoronkov - CEO of Insilico Medicine


Alex Zhavoronkov, PhD, is the founder and CEO of Insilico Medicine (, a leader in next-generation artificial intelligence technologies for drug discovery, biomarker development. He is also the founder and CEO of Deep Longevity, Inc, a global company developing a broad range of artificial intelligence-based biomarkers of ageing and longevity. Since 2015 he invented critical technologies in the field of generative adversarial networks (GANs) and reinforcement learning (RL) for generation of the novel molecular structures with the desired properties and generation of synthetic biological and patient data. He also pioneered the applications of deep learning technologies for prediction of human biological age using multiple data types, transfer learning from ageing into disease, target identification, and signaling pathway modeling.

Hosted by Prof Brian Kennedy.

11am UK time

Visit website:

See also: Academia National University of Singapore (NUS) - Asia’s leading university with a global approach in education, research and service.

Details last updated 27-Jan-2021

Interested in more events? View the club's event calendar.

Mentioned in this Resource

Alex Zhavoronkov

CEO of InSilico Medicine & Deep Longevity. CSO of Biogerontology Research Foundation

Brian Kennedy

Prof of Biochemistry and Physiology at NUS, CSO Ponce De Leon Health

Topics mentioned on this page:
Artificial Intelligence (AI), Biological Age